The stock's fall snapped a three-day winning streak.

This was the stock's third consecutive day of gains.

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -36.36% and 1.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on ...

Aurora Cannabis (ACB.TO)(ACB) has confirmed multiple AI-generated news reports published online Wednesday are false. One of the articles, published on the website Investing.com, claimed the Canadian ...

Aurora Cannabis (NASDAQ:ACB) stock falls as the company cites headwinds in its international markets while reporting better than feared Q4 FY25 revenue. Read more here.

Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the strategy.

Aurora said global cannabis revenue in the current quarter will likely decline from the company’s fourth-quarter level as reduced international sales offset growing Canadian medical cannabis sales.

About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand.